DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depakote (Divalproex) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (54)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakote (Divalproex) disability. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 54   Next >>

Possible Depakote side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Bedridden, Emphysema, Off Label Use, Lung Disorder, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Potassium Chloride (KV / 24)
    Dosage: 8 meq, qd
    Indication: Blood Potassium

Generlac
    Dosage: 30 mg, prn
    Indication: Crohn's Disease

Atenolol
    Dosage: 25 mg, qd
    Administration route: Oral
    Indication: Hypertension

Tylenol
    Dosage: unk unk, qd
    Indication: Migraine

Aspirin
    Dosage: 81 mg, prn
    Indication: Chest Pain

Lantus
    Dosage: 80 units in the moring and 90 units at night
    Indication: Diabetes Mellitus

Lantus
    Dosage: unk

Atropine Sulfate
    Dosage: 2.5 mg, qid
    Administration route: Oral
    Indication: Crohn's Disease

Depakote
    Dosage: 500 mg, bid
    Administration route: Oral
    Indication: Convulsion

Ativan
    Dosage: 1 mg, tid
    Administration route: Oral
    Indication: Nervousness

Zocor
    Dosage: 40 mg, qd
    Administration route: Oral

Zantac
    Dosage: 30 mg, tid
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease

Potassium Chloride

Remeron
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Insomnia

Dilantin
    Dosage: 300 mg, bid
    Administration route: Oral
    Indication: Convulsion

Imdur
    Dosage: 30 mg, tid
    Indication: Cardiac Disorder

Methocarbamol
    Indication: Neuropathy Peripheral

Norvasc
    Administration route: Oral
    Indication: Palpitations

Humulin R
    Dosage: 24 units
    Indication: Diabetes Mellitus

Furosemide
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Diuretic Therapy

Methocarbamol
    Dosage: 750 mg, prn
    Administration route: Oral
    Indication: Muscle Spasms

Nitrostat
    Dosage: 0.4 mg, prn
    Indication: Chest Pain



Possible Depakote side effects in

Reported by a consumer/non-health professional from France on 2012-08-23

Patient:

Reactions: Portal Hypertension, Fatigue, Hypothermia, Anaemia, Epistaxis, Hepatic Cirrhosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Risperidone
    Indication: Bipolar Disorder
    End date: 2011-01-01

Mediator
    Dosage: unk
    Indication: Diabetes Mellitus
    Start date: 2006-01-01
    End date: 2006-01-01

Metformin Hydrochloride

Repaglinide
    Dosage: unk
    Indication: Diabetes Mellitus
    Start date: 2011-05-01
    End date: 2011-01-01

Depakote
    Dosage: 500 mg, unk
    Indication: Bipolar Disorder
    End date: 2006-01-01

Diamicron
    Dosage: 60 mg, unk
    Indication: Diabetes Mellitus
    End date: 2011-01-01

Glucophage
    Dosage: unk

Glucophage
    Administration route: Oral

Sitagliptin Phosphate
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2009-04-01
    End date: 2011-01-01

Glucophage
    Indication: Diabetes Mellitus
    End date: 2011-01-01

Abilify
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Metformin Hydrochloride
    Dosage: unk
    Indication: Diabetes Mellitus
    End date: 2011-05-01

Insulin
    Dosage: unk
    Start date: 2011-05-01



Possible Depakote side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22

Patient:

Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Methocarbamol
    Administration route: Oral

Furosemide
    Administration route: Oral

Dilantin
    Administration route: Oral

Potassium Chloride

Depakote
    Administration route: Oral

Aspirin

Lomotil
    Administration route: Oral

Humulin R

Lantus
    Dosage: 80 iu, qam

Nitrostat

Ativan
    Administration route: Oral

Zantac

Atenolol
    Administration route: Oral

Lantus
    Dosage: 90 df, qpm

Zocor
    Administration route: Oral

Generlac

Norvasc
    Administration route: Oral

Tylenol W / Codeine NO. 3

Remeron
    Administration route: Oral

Isosorbide Mononitrate



Possible Depakote side effects in

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient:

Reactions: Bedridden, Emphysema, Chronic Obstructive Pulmonary Disease, Amnesia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Norvasc
    Administration route: Oral

Dilantin
    Dosage: 300 mg, bid
    Administration route: Oral

Tylenol W / Codeine
    Dosage: unk, qd

Lantus
    Dosage: 80 iu, qam

Lantus
    Dosage: 90 iu, qpm

Lomotil
    Dosage: 2.5 mg, qid
    Administration route: Oral

Isosorbide Mononitrate
    Dosage: 30 mg, tid

Potassium Chloride
    Dosage: 8 meq, qd

Depakote
    Dosage: 500 mg, bid
    Administration route: Oral

Methocarbamol
    Dosage: 750 mg, prn
    Administration route: Oral

Lactulose
    Dosage: 30 mg, prn

Atenolol
    Dosage: 25 mg, qd
    Administration route: Oral

Nitrostat
    Dosage: 0.4 mg, prn

Aspirin
    Dosage: 81 mg, prn

Ativan
    Dosage: 1 mg, tid
    Administration route: Oral

Zocor
    Dosage: 40 mg, qd
    Administration route: Oral

Furosemide
    Dosage: 40 mg, bid
    Administration route: Oral

Humulin R
    Dosage: 24 iu, tid

Zantac
    Dosage: 300 mg, tid

Remeron
    Dosage: 30 mg, qd
    Administration route: Oral



Possible Depakote side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient:

Reactions: Bedridden, Emphysema, Chronic Obstructive Pulmonary Disease, Amnesia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Zocor
    Dosage: 40 mg, unk
    Administration route: Oral

Humulin R
    Dosage: 24 iu, tid

Depakote
    Dosage: 500 mg, bid
    Administration route: Oral

Ativan
    Dosage: 1 mg, tid
    Administration route: Oral

Zantac
    Dosage: 300 mg, tid

Dilantin
    Dosage: 300 mg, bid
    Administration route: Oral

Remeron
    Dosage: 30 mg, unk
    Administration route: Oral

Isosorbide Mononitrate
    Dosage: 30 mg, tid

Lomotil
    Dosage: 2.5 (4 in d) mg,
    Administration route: Oral

Lantus
    Dosage: 80 iu, unk

Furosemide
    Dosage: 40 mg, bid
    Administration route: Oral

Aspirin
    Dosage: 81 mg, prn

Nitrostat
    Dosage: 0.4 mg, prn

Atenolol
    Dosage: 25 mg, qd
    Administration route: Oral

Tylenol (Caplet)
    Dosage: 1 df, qd

Lantus
    Dosage: 90 iu, unk

Potassium Chloride
    Dosage: 8 meq, qd

Norvasc
    Dosage: unk
    Administration route: Oral

Lactulose
    Dosage: 30 mg, prn

Methocarbamol
    Dosage: 750 mg, prn
    Administration route: Oral



Possible Depakote side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient:

Reactions: Bedridden, Emphysema, Chronic Obstructive Pulmonary Disease, Amnesia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Zocor
    Administration route: Oral

Zantac

Methocarbamol
    Administration route: Oral

Isosorbide Mononitrate

Nitrostat

Dilantin
    Administration route: Oral

Remeron
    Administration route: Oral

Potassium Chloride

Depakote
    Administration route: Oral

Lantus
    Dosage: 90 df, qpm

Atenolol
    Administration route: Oral

Ativan
    Administration route: Oral

Furosemide
    Administration route: Oral

Norvasc
    Administration route: Oral

Generlac

Tylenol W / Codeine NO. 3

Lomotil
    Administration route: Oral

Humulin R

Aspirin

Lantus
    Dosage: 80 iu, qam



Possible Depakote side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient:

Reactions: Product Quality Issue, Bedridden, Emphysema, Lung Disorder, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Atenolol
    Dosage: 25 mg, qd
    Administration route: Oral

Nitrostat
    Dosage: 0.4 mg, prn

Lantus
    Dosage: 170 df, qd

Tylenol W / Codeine NO. 3
    Dosage: unk, qd

Methocarbamol
    Dosage: 750 mg, prn
    Administration route: Oral

Dilantin
    Dosage: 300 mg, bid
    Administration route: Oral

Zocor
    Dosage: 40 mg, qd
    Administration route: Oral

Norvasc
    Administration route: Oral

Depakote
    Dosage: 500 mg, bid
    Administration route: Oral

Humulin R
    Dosage: 24 df, tid

Ativan
    Dosage: 1 mg, tid
    Administration route: Oral

Potassium Chloride
    Dosage: 8 meq, unk

Aspirin
    Dosage: 81 mg, prn
    Administration route: Oral

Lomotil
    Dosage: 2.5 mg, qid
    Administration route: Oral

Isosorbide Mononitrate
    Dosage: 30 mg, tid
    Administration route: Oral

Zantac
    Dosage: 300 mg, tid

Furosemide
    Dosage: 40 mg, bid
    Administration route: Oral

Lactulose
    Dosage: 30 mg, prn

Remeron
    Dosage: 30 mg, qd
    Administration route: Oral



Possible Depakote side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient:

Reactions: Emphysema, Bedridden, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Lomotil
    Dosage: 2.5 mg, qid
    Administration route: Oral
    Indication: Crohn's Disease

Atenolol
    Dosage: 25 mg, qd
    Administration route: Oral
    Indication: Hypertension

Tylenol W / Codeine NO. 3
    Dosage: unk unk, qd
    Indication: Migraine

Nitrostat
    Dosage: 0.4 mg, prn
    Indication: Chest Pain

Generlac
    Dosage: 30 mg, prn
    Indication: Crohn's Disease

Furosemide
    Dosage: 40 mg, bid
    Administration route: Oral

Potassium Chloride
    Dosage: 8 meq, qd
    Indication: Mineral Supplementation

Zantac
    Dosage: 300 mg, tid
    Indication: Gastrooesophageal Reflux Disease

Aspirin
    Dosage: 81 mg, prn
    Indication: Chest Pain

Remeron
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Insomnia

Zocor
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Lantus
    Dosage: 80 units in morning, 90 units at night
    Indication: Diabetes Mellitus

Humulin R
    Dosage: 24 iu, tid
    Indication: Diabetes Mellitus

Methocarbamol
    Dosage: 750 mg, prn
    Administration route: Oral
    Indication: Muscle Spasms

Methocarbamol
    Dosage: unk
    Indication: Neuropathy Peripheral

Dilantin
    Dosage: 300 mg, bid
    Administration route: Oral
    Indication: Convulsion

Isosorbide Mononitrate
    Dosage: 30 mg, tid
    Indication: Cardiac Disorder

Depakote
    Dosage: 500 mg, bid
    Administration route: Oral
    Indication: Convulsion

Ativan
    Dosage: 1 mg, tid
    Administration route: Oral
    Indication: Nervousness

Norvasc
    Administration route: Oral
    Indication: Cardiac Disorder

Norvasc
    Indication: Lung Disorder



Possible Depakote side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: 51 year old female

Reactions: Fatigue, Hypothermia, Anaemia, Hepatic Cirrhosis, Epistaxis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Risperidone
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Glucophage
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Repaglinide
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Metformin HCL
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Abilify
    Dosage: jun2009,15mg/d
    Indication: Bipolar Disorder
    Start date: 2009-01-01
    End date: 2011-01-01

Metformin Hydrochloride
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Depakote
    Dosage: depakote 500 mg
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Sitagliptin Phosphate
    Dosage: xelevia 100 mg xelevia 1000 mg
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Mediator
    Indication: Diabetes Mellitus
    Start date: 2006-01-01
    End date: 2009-01-01

Diamicron
    Dosage: diamicron 60mg
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Glucophage
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Other drugs received by patient: Delursan



Possible Depakote side effects in 51 year old female

Reported by a consumer/non-health professional from France on 2012-07-18

Patient: 51 year old female

Reactions: Fatigue, Hypothermia, Anaemia, Hepatic Cirrhosis, Epistaxis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Risperidone
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Repaglinide
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Diamicron
    Dosage: diamicron 60mg
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Glucophage
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Abilify
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Depakote
    Dosage: depakote 500 mg
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Glucophage
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Metformin HCL
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Sitagliptin Phosphate
    Dosage: xelevia 100 mg xelevia 1000 mg
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Metformin Hydrochloride
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Mediator
    Indication: Diabetes Mellitus
    Start date: 2006-01-01
    End date: 2009-01-01

Other drugs received by patient: Delursan



Possible Depakote side effects in

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient:

Reactions: Anxiety, Cardiac Flutter, Atrial Fibrillation

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Depakote



Possible Depakote side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-22

Patient: 59 year old male

Reactions: Hepatic Enzyme Increased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Depakote

Other drugs received by patient: Perphenazine; Cephalexin; Diphenhydramine 10 MG; Benztropine Mesylate; Protein; Lorazepam; Haloperidol; Albumin (Human); Bilirubin; Divalproex Sodium; Ziprasidone HCL



Possible Depakote side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-12

Patient: 51 year old female

Reactions: Fatigue, Hypothermia, Anaemia, Epistaxis, Hepatic Cirrhosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Abilify
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Repaglinide
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Glucophage
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Metformin HCL
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Metformin Hydrochloride
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Risperidone
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Depakote
    Dosage: depakote 500 mg
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Glucophage
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Diamicron
    Dosage: diamicron 60mg
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Mediator
    Indication: Diabetes Mellitus
    Start date: 2006-01-01
    End date: 2009-01-01

Sitagliptin Phosphate
    Dosage: xelevia 100 mg xelevia 1000 mg
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01



Possible Depakote side effects in 55 year old female

Reported by a consumer/non-health professional from United States on 2012-06-07

Patient: 55 year old female, weighing 77.1 kg (169.6 pounds)

Reactions: Agitation, Dyskinesia, Deafness, Amnesia, Tremor, Anxiety, Dyspepsia, Grip Strength Decreased, Vision Blurred, Eye Movement Disorder

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Depakote



Possible Depakote side effects in 58 year old male

Reported by a consumer/non-health professional from United States on 2012-05-22

Patient: 58 year old male, weighing 65.8 kg (144.7 pounds)

Reactions: Burning Sensation, Mania

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Clopazim
    Dosage: 200mg morning
    Indication: Bipolar I Disorder

Depakote
    Dosage: 200 m 300 e morning evening

Other drugs received by patient: Abilify; Colozeral



Possible Depakote side effects in 51 year old female

Reported by a consumer/non-health professional from Germany on 2012-05-11

Patient: 51 year old female

Reactions: Fatigue, Hypothermia, Anaemia, Hepatic Cirrhosis, Epistaxis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Repaglinide
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Abilify
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Metformin HCL
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Glucophage
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Depakote
    Dosage: depakote 500 mg
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01

Diamicron
    Dosage: diamicron 60mg
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Mediator
    Indication: Diabetes Mellitus
    Start date: 2006-01-01
    End date: 2009-01-01

Glucophage
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Sitagliptin Phosphate
    Dosage: xelevia 100 mg xelevia 1000 mg
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Metformin Hydrochloride
    Indication: Diabetes Mellitus
    Start date: 2002-01-01
    End date: 2011-01-01

Risperidone
    Indication: Bipolar Disorder
    Start date: 1995-01-01
    End date: 2011-01-01



Possible Depakote side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-26

Patient: male, weighing 63.5 kg (139.7 pounds)

Reactions: Rash Erythematous, Breast Mass, Gait Disturbance, Bone Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Zyprexa
    Dosage: 10 mg ? 1x/day p.o. 6 or 8 of '09 til 11-11
    Administration route: Oral
    Indication: Anger

Depakote
    Dosage: 500 mg ? 1 x / day p.o. 6 or 8 of '09 til 11-'11

Other drugs received by patient: Fish OIL; Vitamin C; Multi-Vitamin



Possible Depakote side effects in 48 year old female

Reported by a individual with unspecified qualification from United States on 2012-04-13

Patient: 48 year old female, weighing 90.0 kg (198.0 pounds)

Reactions: Bedridden, Emphysema, Product Quality Issue, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Lomotil
    Dosage: 10 mg (2.5 mg,4 in 1 d),oral
    Administration route: Oral
    Indication: Crohn's Disease

Potassium Chloride
    Dosage: (8 milliequivalents-
    Indication: Blood Potassium Normal

Methocarbamol
    Dosage: (750 mg,as required),oral
    Administration route: Oral
    Indication: Muscle Spasms

Aspirin
    Dosage: (81 mg,as required)
    Indication: Chest Pain

Furosemide
    Dosage: 80 mg (40 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Diuretic Therapy

Isosorbide Mononitrate
    Dosage: 90 mg (30 mg,3 in 1 d)
    Indication: Cardiac Disorder

Remeron
    Dosage: (30 mg,1 d),oral
    Administration route: Oral
    Indication: Insomnia

Atenolol
    Dosage: (25 mg,1 d),oral
    Administration route: Oral
    Indication: Hypertension

Humulin R
    Dosage: 72 iu (24 iu,3 in 1 d)
    Indication: Diabetes Mellitus

Lantus
    Dosage: (170, 80 units morning and 90 units night)
    Indication: Diabetes Mellitus

Ativan
    Dosage: 3 mg (1 mg,3 in 1 d),oral
    Administration route: Oral
    Indication: Anxiety

Depakote
    Dosage: 1000 mg (500 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Convulsion

Norvasc
    Dosage: oral
    Administration route: Oral
    Indication: Cardiac Disorder

Dilantin
    Dosage: 600 mg (300 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Tylenol W / Codeine NO. 3
    Dosage: (1 d)
    Indication: Migraine

Simvastatin
    Dosage: (40 mg,1 d),oral
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Nitrostat
    Dosage: (0.4 mg,as required)
    Indication: Chest Pain

Lactulose
    Dosage: (30 mg,as required)
    Indication: Crohn's Disease

Zantac
    Dosage: 900 mg (300 mg,3 in 1 d)
    Indication: Gastrooesophageal Reflux Disease



Possible Depakote side effects in 48 year old female

Reported by a individual with unspecified qualification from United States on 2012-04-11

Patient: 48 year old female, weighing 90.0 kg (198.0 pounds)

Reactions: Bedridden, Emphysema, Chronic Obstructive Pulmonary Disease, Amnesia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Simvastatin
    Dosage: (40 mg,1 d),oral
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Aspirin
    Dosage: (81 mg,as required)
    Indication: Chest Pain

Depakote
    Dosage: 1000 mg (500 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Convulsion

Humulin R
    Dosage: 72 iu (24 iu,3 in 1 d)
    Indication: Diabetes Mellitus

Dilantin
    Dosage: 600 mg (300 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Isosorbide Mononitrate
    Dosage: 90 mg (30 mg,3 in 1 d)
    Indication: Cardiac Disorder

Zantac
    Dosage: 900 mg (300 mg,3 in 1 d),

Remeron
    Dosage: (30 mg,1 d),oral
    Administration route: Oral

Methocarbamol
    Dosage: (750 mg,as required),oral
    Administration route: Oral
    Indication: Blood Potassium Abnormal

Methocarbamol
    Dosage: (750 mg,as required),oral
    Administration route: Oral
    Indication: Muscle Spasms

Atenolol
    Dosage: (25 mg,1 d),oral
    Administration route: Oral
    Indication: Hypertension

Lactulose
    Dosage: (30 mg,as required)
    Indication: Crohn's Disease

Lomotil
    Dosage: 10 mg (2.5 mg,4 in 1 d),oral
    Administration route: Oral
    Indication: Crohn's Disease

Nitrostat
    Dosage: (0.4 mg,as required)
    Indication: Chest Pain

Potassium Chloride
    Dosage: (8 milliequivalents,1 d)
    Indication: Blood Pressure Abnormal

Norvasc
    Dosage: oral
    Administration route: Oral
    Indication: Cardiac Disorder

Norvasc
    Dosage: oral
    Administration route: Oral
    Indication: Lung Disorder

Furosemide
    Dosage: 80 mg (40 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Diuretic Therapy

Tylenol W / Codeine NO. 3
    Dosage: (1 d)
    Indication: Migraine

Lantus
    Dosage: (170 , 80 units morning and 90 units night)
    Indication: Diabetes Mellitus

Ativan
    Dosage: 3 mg (1 mg,3 in 1 d),oral
    Administration route: Oral



Possible Depakote side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-11

Patient: female, weighing 53.5 kg (117.7 pounds)

Reactions: Self Injurious Behaviour

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Depakote



Possible Depakote side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-09

Patient: female, weighing 53.5 kg (117.7 pounds)

Reactions: Intentional Self-Injury

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Depakote



Possible Depakote side effects in 48 year old female

Reported by a consumer/non-health professional from United States on 2012-04-06

Patient: 48 year old female, weighing 90.0 kg (198.0 pounds)

Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Lomotil
    Administration route: Oral
    Indication: Crohn's Disease

Ativan
    Administration route: Oral
    Indication: Anxiety

Methocarbamol
    Administration route: Oral
    Indication: Neuropathy Peripheral

Furosemide
    Administration route: Oral
    Indication: Diuretic Therapy

Atenolol
    Administration route: Oral
    Indication: Hypertension

Zantac
    Indication: Gastrooesophageal Reflux Disease

Humulin R
    Indication: Diabetes Mellitus

Simvastatin
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Lantus
    Dosage: 80 units in the morning and 90 units in the night
    Indication: Diabetes Mellitus

Norvasc
    Administration route: Oral
    Indication: Cardiac Disorder

Tylenol W / Codeine NO. 3
    Indication: Migraine

Aspirin
    Indication: Chest Pain

Nitrostat
    Indication: Chest Pain

Methocarbamol
    Administration route: Oral
    Indication: Muscle Spasms

Isosorbide Mononitrate
    Indication: Cardiac Disorder

Potassium Chloride
    Indication: Blood Potassium Abnormal

Depakote
    Administration route: Oral
    Indication: Convulsion

Generlac
    Indication: Crohn's Disease

Remeron
    Administration route: Oral
    Indication: Insomnia

Norvasc
    Administration route: Oral
    Indication: Lung Disorder

Dilantin
    Administration route: Oral
    Indication: Convulsion

AN Unknown Medication
    Indication: Depression



Possible Depakote side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-05

Patient: female, weighing 90.0 kg (198.0 pounds)

Reactions: Emphysema, Bedridden, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Lomotil
    Dosage: 2.5 mg, 4x/day
    Administration route: Oral
    Indication: Crohn's Disease

Dilantin
    Dosage: 300 mg, 2x/day
    Administration route: Oral

Lactulose
    Dosage: 30 mg solution, as needed
    Indication: Crohn's Disease

Simvastatin
    Dosage: 40 mg, daily
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Potassium Chloride
    Dosage: 8 meq, daily
    Indication: Blood Potassium Abnormal

Aspirin
    Dosage: 81 mg, as needed
    Indication: Chest Pain

Lantus
    Dosage: 80units in the morning and 90 units at night
    Indication: Diabetes Mellitus

Tylenol W / Codeine NO. 3
    Dosage: unk daily
    Indication: Migraine

Methocarbamol
    Indication: Neuropathy Peripheral

Atenolol
    Dosage: 25 mg, daily
    Administration route: Oral
    Indication: Hypertension

Furosemide
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Diuretic Therapy

Isosorbide Mononitrate
    Dosage: 30 mg, 3x/day
    Indication: Cardiac Disorder

Depakote
    Dosage: 500 mg, 2x/day
    Administration route: Oral
    Indication: Convulsion

Ativan
    Dosage: 1 mg, 3x/day
    Administration route: Oral
    Indication: Anxiety

Methocarbamol
    Dosage: 750 mg, as needed
    Administration route: Oral
    Indication: Muscle Spasms

Zantac
    Dosage: 300 mg, 3x/day
    Indication: Gastrooesophageal Reflux Disease

Remeron
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Insomnia

Norvasc
    Dosage: unk
    Administration route: Oral
    Indication: Cardiac Disorder

Norvasc
    Indication: Lung Disorder

Nitrostat
    Dosage: 0.4 mg, as needed
    Indication: Chest Pain

Humulin R
    Dosage: 24 iu, 3x/day
    Indication: Diabetes Mellitus



Possible Depakote side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-03

Patient: female, weighing 90.0 kg (198.0 pounds)

Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Methocarbamol
    Indication: Neuropathy Peripheral

Dilantin
    Dosage: 300 mg, 2x/day
    Administration route: Oral

Simvastatin
    Dosage: 40 mg, daily
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Lactulose
    Dosage: 30 mg solution, as needed
    Indication: Crohn's Disease

Depakote
    Dosage: 500 mg, 2x/day
    Administration route: Oral
    Indication: Convulsion

Humulin R
    Dosage: 24 iu, 3x/day
    Indication: Diabetes Mellitus

Tylenol W / Codeine NO. 3
    Dosage: unk daily
    Indication: Migraine

Zantac
    Dosage: 300 mg, 3x/day
    Indication: Gastrooesophageal Reflux Disease

Isosorbide Dinitrate
    Dosage: 30 mg, 3x/day
    Indication: Cardiac Disorder

Potassium Chloride
    Dosage: 8 meq, daily
    Indication: Blood Potassium Abnormal

Furosemide
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Diuretic Therapy

Remeron
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Insomnia

Atenolol
    Dosage: 25 mg, daily
    Administration route: Oral
    Indication: Hypertension

Methocarbamol
    Dosage: 750 mg, as needed
    Administration route: Oral
    Indication: Muscle Spasms

Aspirin
    Dosage: 81 mg, as needed
    Indication: Chest Pain

Lantus
    Dosage: 80units in the morning and 90 units at night
    Indication: Diabetes Mellitus

Ativan
    Dosage: 1 mg, 3x/day
    Administration route: Oral
    Indication: Anxiety

Norvasc
    Dosage: unk
    Administration route: Oral
    Indication: Cardiac Disorder

Norvasc
    Indication: Lung Disorder

Nitrostat
    Dosage: 0.4 mg, as needed
    Indication: Chest Pain

Lomotil
    Dosage: 2.5 mg, 4x/day
    Administration route: Oral
    Indication: Crohn's Disease



Possible Depakote side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-30

Patient: female, weighing 86.2 kg (189.6 pounds)

Reactions: Weight Increased, Syncope, Visual Acuity Reduced, Mental Retardation, Unevaluable Event, Unemployment

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Prolixin

Risperidol / Alonzopin
    Dosage: 25mg- fried me shots
    Start date: 1983-01-01
    End date: 1984-01-01

Depakote

Haldol
    Dosage: 25 mg - 100mg fried me shots
    Start date: 1997-01-01
    End date: 1998-01-01



Possible Depakote side effects in 48 year old female

Reported by a consumer/non-health professional from United States on 2012-03-29

Patient: 48 year old female, weighing 89.8 kg (197.6 pounds)

Reactions: Emphysema, Bedridden, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Lantus
    Dosage: 80units in the morning and 90 units at night
    Indication: Diabetes Mellitus

Isosorbide Mononitrate
    Indication: Cardiac Disorder

Norvasc
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis

Unspecified Medication
    Indication: Depression

Dilantin
    Administration route: Oral
    Indication: Convulsion

Methocarbamol
    Administration route: Oral
    Indication: Neuropathy Peripheral

Potassium Chloride
    Indication: Blood Potassium Abnormal

Aspirin
    Indication: Chest Pain

Lomotil
    Administration route: Oral
    Indication: Crohn's Disease

Ativan
    Administration route: Oral
    Indication: Nervousness

Generlac
    Indication: Crohn's Disease

Zantac
    Indication: Gastrooesophageal Reflux Disease

Humulin R
    Indication: Diabetes Mellitus

Tylenol W / Codeine
    Dosage: daily
    Indication: Migraine

Remeron
    Administration route: Oral
    Indication: Insomnia

Depakote
    Administration route: Oral
    Indication: Convulsion

Atenolol
    Administration route: Oral
    Indication: Hypertension

Furosemide
    Administration route: Oral
    Indication: Diuretic Therapy

Simvastatin
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Methocarbamol
    Administration route: Oral
    Indication: Muscle Spasms

Nitrostat
    Indication: Chest Pain



Possible Depakote side effects in 53 year old female

Reported by a consumer/non-health professional from United States on 2012-03-15

Patient: 53 year old female, weighing 59.0 kg (129.8 pounds)

Reactions: Mood Altered, Drug Ineffective, Impaired Work Ability, General Physical Health Deterioration, Blindness, Disability

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Keppra
    Indication: Convulsion
    Start date: 2011-10-06
    End date: 2011-10-01

Gabapentin
    Dosage: total daily dose: 2800 mg (1200 mg in noon and 800 mg in morning and at bedtime)
    Indication: Convulsion
    Start date: 2009-11-01

Gabapentin
    Dosage: total daily dose: 2800 mg (1200 mg in noon and 800 mg in morning and at bedtime)
    Start date: 1996-03-01

Depakote
    Indication: Convulsion
    Start date: 2011-10-27
    End date: 2011-11-28

Valproic Acid
    Indication: Convulsion

Other drugs received by patient: Savella; Soma



Possible Depakote side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-02

Patient: female, weighing 89.8 kg (197.6 pounds)

Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Humulin R
    Dosage: 24 iu tid
    Indication: Diabetes Mellitus

Lomotil
    Dosage: 2.5 mg qid oral
    Administration route: Oral
    Indication: Crohn's Disease

Atenolol
    Dosage: 25 mg qd oral
    Administration route: Oral
    Indication: Hypertension

Nitrostat
    Dosage: 0.4 mg, as needed
    Indication: Chest Pain

Depakote
    Dosage: 500 mg bid oral
    Administration route: Oral
    Indication: Convulsion

Simvastatin
    Dosage: 40 mg qd oral
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Acetaminophen W / Codeine NO. 3
    Dosage: df, dail
    Indication: Migraine

Methocarbamol
    Dosage: 750 mg, as needed oral
    Administration route: Oral
    Indication: Muscle Spasms

Methocarbamol
    Dosage: 750 mg, as needed oral
    Administration route: Oral
    Indication: Neuropathy Peripheral

Remeron
    Dosage: 30 mg qd oral
    Administration route: Oral
    Indication: Insomnia

Ativan
    Dosage: 1 mg tid oral
    Administration route: Oral
    Indication: Nervousness

Lantus
    Dosage: 170 iu, 80 units in the morning and 90 units at night
    Indication: Diabetes Mellitus

Antidepressants
    Dosage: df
    Indication: Depression

Isosorbide Mononitrate
    Dosage: 30 mg tid
    Indication: Cardiac Disorder

Generlac
    Dosage: 30 mg, as needed
    Indication: Crohn's Disease

Furosemide
    Dosage: 40 mg bid oral
    Administration route: Oral
    Indication: Diuretic Therapy

Potassium Chloride
    Dosage: 8 meq qd
    Indication: Mineral Supplementation

Dilantin
    Dosage: 300 mg bid oral
    Administration route: Oral
    Indication: Convulsion

Zantac
    Dosage: 300 mg tid
    Indication: Gastrooesophageal Reflux Disease

Aspirin
    Dosage: 81 mg, as needed
    Indication: Chest Pain

Norvasc
    Dosage: df oral
    Administration route: Oral
    Indication: Cardiac Disorder



Possible Depakote side effects in 48 year old female

Reported by a consumer/non-health professional from United States on 2012-03-01

Patient: 48 year old female, weighing 90.0 kg (198.0 pounds)

Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Lomotil
    Administration route: Oral
    Indication: Crohn's Disease

Potassium Chloride
    Indication: Mineral Supplementation

Norvasc
    Administration route: Oral
    Indication: Lung Disorder

Generlac
    Indication: Crohn's Disease

Atenolol
    Administration route: Oral
    Indication: Hypertension

Norvasc
    Administration route: Oral
    Indication: Cardiac Disorder

Remeron
    Administration route: Oral
    Indication: Insomnia

Lantus
    Indication: Diabetes Mellitus

Zantac
    Indication: Gastrooesophageal Reflux Disease

Humulin R
    Indication: Diabetes Mellitus

Dilantin
    Administration route: Oral
    Indication: Convulsion

Tylenol W / Codeine NO. 3
    Indication: Migraine

Methocarbamol
    Administration route: Oral
    Indication: Muscle Spasms

Nitrostat
    Indication: Chest Pain

Aspirin
    Indication: Chest Pain

Zocor
    Administration route: Oral
    Indication: Blood Cholesterol Increased

Furosemide
    Administration route: Oral

Ativan
    Administration route: Oral
    Indication: Nervousness

Isosorbide Mononitrate
    Indication: Cardiac Disorder

Depakote
    Administration route: Oral
    Indication: Convulsion

Methocarbamol
    Administration route: Oral
    Indication: Neuropathy Peripheral



Possible Depakote side effects in 50 year old female

Reported by a individual with unspecified qualification from United States on 2012-02-28

Patient: 50 year old female, weighing 58.5 kg (128.7 pounds)

Reactions: Drug Ineffective, Convulsion

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gabapentin
    Dosage: (1200 mg, in noon), unknown
    Indication: Product Used FOR Unknown Indication
    Start date: 1996-03-01

Depakote
    Dosage: 500 mg (250 mg, 2 in 1 d), unknown
    Indication: Convulsion
    Start date: 2011-10-27
    End date: 2011-11-28

Kepra (Levetiracetam)
    Dosage: 500 mg (250 mg, 2 in 1 d), unknown
    Indication: Convulsion
    Start date: 2011-10-06
    End date: 2011-10-01

Valproic Acid
    Indication: Convulsion

Other drugs received by patient: Savella (Milnaciproan Hydrochloride); Soma



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014